Page last updated: 2024-11-05

trihexyphenidyl and Aprosodia

trihexyphenidyl has been researched along with Aprosodia in 6 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"DYT16 is an autosomal recessive dystonia-parkinsonism due to putative mutations at PRKRA gene."1.38DYT16: the original cases. ( Camargos, S; Cardoso, F; Lees, AJ; Singleton, A, 2012)
"Focal dystonia of the right hand and speech impairment as a result of a circumscribed left-sided anterior thalamic lesion is reported in a 9-year-old girl with borderline normal psychomotor development."1.29Focal dystonia and speech impairment responding to anticholinergic therapy. ( Maassen, B; Merx, JL; Rotteveel, JJ; Vogels, OJ, 1994)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patel, AS1
Sulica, L1
Frucht, SJ1
Blackburn, JS1
Cirillo, ML1
Camargos, S1
Lees, AJ1
Singleton, A1
Cardoso, F1
Vogels, OJ1
Maassen, B1
Rotteveel, JJ1
Merx, JL1
Wolf, SM1
Duvoisin, RC1
Katz, R1

Other Studies

6 other studies available for trihexyphenidyl and Aprosodia

ArticleYear
Velopharyngeal Dystonia: An Unusual Focal Task-specific Dystonia?
    Tremor and other hyperkinetic movements (New York, N.Y.), 2017, Volume: 7

    Topics: Adult; Cholinergic Antagonists; Dystonic Disorders; Female; Humans; Male; Middle Aged; Speech Disord

2017
Clinical reasoning: A 13-year-old boy presenting with dystonia, myoclonus, and anxiety.
    Neurology, 2012, Mar-13, Volume: 78, Issue:11

    Topics: Adolescent; Anti-Dyskinesia Agents; Anxiety; Diagnosis, Differential; Dystonia; Genetic Testing; Han

2012
DYT16: the original cases.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:10

    Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Baclofen; Biperiden;

2012
Focal dystonia and speech impairment responding to anticholinergic therapy.
    Pediatric neurology, 1994, Volume: 11, Issue:4

    Topics: Cerebral Infarction; Child; Dystonia; Female; Humans; Language Development Disorders; Language Tests

1994
Reserpine: cause and treatment of oral-facial dyskinesia.
    Bulletin of the Los Angeles neurological societies, 1973, Volume: 38, Issue:2

    Topics: Deglutition Disorders; Diazepam; Face; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged

1973
Reversal of central anticholinergic syndrome in man by physostigmine.
    JAMA, 1968, Nov-25, Volume: 206, Issue:9

    Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Halluci

1968